The Trump administration has begun reviewing incentive agreements under the CHIPS and Science Act (hereinafter the CHIPS Act), signaling potential renegotiations and delays in upcoming subsidy disbursements.

administrator
Related Articles
Pharmacists Can Intervene in Commonly Overlooked Medication Errors
- September 12, 2025